title: [Adjuvant therapeutic possibilities in carcinoma of colon and rectum].
abstract: Recently published results of large randomized trials have changed the recommendations for adjuvant treatment in patients with colorectal cancer. Patients with Dukes C cancer of the large bowel should be treated with a combination of Levamisole and 5-FU. For patients with rectal carcinoma Dukes B and C, a combined chemo-/radiotherapy is recommended.
authors.affiliation: Medizinische Universitätsklinik, Tübingen.
authors.forename: B
authors.initials: B
authors.lastname: Steinke
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D003082:Colectomy; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage
chemical_list: D007978:Levamisole; D005472:Fluorouracil
vernacular_title: Adjuvante Therapiemöglichkeiten bei Kolon- und Rektumkarzinomen.